Lawrence D. Kaplan

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

Donald W. Northfelt, Bruce J. Dezube, James Thommes et al. · Journal of Clinical Oncology · 1998 · 639 citations

Pegylated-liposomal Doxorubicin, Medicine, Immunology +13

Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)

James L. Rubenstein, Eric D. Hsi, Jeffrey L. Johnson et al. · Journal of Clinical Oncology · 2013 · 489 citations · Full text

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010

Lawrence D. Kaplan · Blood · 2005 · 413 citations · Full text

Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus Infection

Lawrence D. Kaplan, David J. Straus, Marcia A. Testa et al. · New England Journal of Medicine · 1997 · 378 citations · Full text

Chemotherapy for Human Immunodeficiency Virus–Associated Non-Hodgkin’s Lymphoma in Combination With Highly Active Antiretroviral Therapy

Lee Ratner, Jeannette Y. Lee, Shenghui Tang et al. · Journal of Clinical Oncology · 2001 · 278 citations